Expanding evidence-based cancer treatment options

Cancer treatment optionsExpanding evidence-based cancer treatment options

Reliable Cancer Therapies (RCT) is a non-profit organization providing research-based information on cancer therapies and selectively funding the development of promising therapies.

 

Welcome

RCT investigates the information on cancer therapies for evidence, so that evidence-based treatment choices can be made. We help patients to structure and absorb the complex nature of the information on registered, complementary or alternative therapies.

RCT is continuously looking for cancer therapies that have never been thoroughly examined and might finance the treatments that can be deemed promising based on measurable results.

The RCT website provides the same research-based information in an adapted language for patients and their relatives, and for professionals so that it can be used to discuss treatment options. The RCT team is independent and open-minded, is supported by a high level advisory board, is collaborating with international organizations (ESMO, CAM-CANCER) and consults reliable sources (NCI, MSKcc, NS, a.o.). RCT does not provide medical advice and our website does not replace a medical consultation.

What can you find on the website ?

  • Information on various cancer therapies and types
  • Guides for patients per cancer type
  • Guides with general information
  • Overview of RCT-supported projects
  • Questions answered by our team
  • Links to clinical trials

Search

Enter a term in the search box, or click on a specific tab or on the green underlined terms

In the spotlight

FLUVABREX, a phase I study assessing the safety of the association of fluvastatin in addition to celecoxib in children with refractory optic-pathway glioma

Optic-pathway gliomas are rare tumors accounting for 1 to 5% of all brain tumors in children. The current treatment strategy in children with optic glioma symptoms is chemotherapy to postpone radiotherapy on the developing brain of a child as much as possible.
In this Phase I study, the safety of a combination of the 2 drugs celecoxib and fluvastatin in children with optic-pathway gliomas will be verified.

RCT news

RCT supports the ‘Fluvabrex’ and ‘Ketorolac’ trials

Reliable Cancer Therapies has decided to financially support the research of two promising cancer treatments, Fluvabrex and Ketorolac. What is particularly interesting about these studies, is the fact that both Fluvabrex and Ketorolac are already approved and are used in hospitals for other indications than cancer.

Advisory Board

Reliable Cancer Therapies is supported by an Advisory Board.

'…the ultimate goal of cancer treatment to eradicate all cancer cells is probably not always realistic: successful symbiosis with residual cancer cells is often a more feasible alternative… '
Marc Bracke
'In the war against cancer, magic bullets may not exist and evolution dictates the rules of engagement.'
Robert Gatenby
'In God we trust, all others must bring data' W.Edwards Deming.'
Bert Aertgeerts
'A better understanding of the disease and its treatment options is empowering patients and helping them to fight the disease better: this is why Reliable Cancer Therapies is a wonderful initiative!'
Martine Piccart

This site complies with the HONcode standard for trustworthy health informtion

Verify here.